Zealand Pharma A/s Stock
€48.17
Your prediction
Zealand Pharma A/s Stock
Pros and Cons of Zealand Pharma A/s in the next few years
Pros
Cons
Performance of Zealand Pharma A/s vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Zealand Pharma A/s | -1.650% | -5.663% | -14.520% | -48.224% | -23.445% | 63.158% | - |
| Saniona AB | -2.050% | -2.227% | -4.565% | 254.032% | 14.442% | 731.439% | 30.810% |
| Ocuphire Pharma Inc. | -2.580% | 1.142% | 53.086% | 201.556% | 84.304% | -6.203% | - |
| Immunic Inc. | 1.840% | -1.425% | 30.981% | -33.363% | 76.977% | -57.415% | -94.363% |
News
Why 2026 Could Be Another Breakout Year for Rocket Lab
The momentum has shown little sign of slowing for Rocket Lab (NASDAQ: RKLB). Shares of the aerospace and defense company have gone from strength to strength, rising roughly 1,775% over the past
New APAC Partnership with Matter Brings Market Logic Software's Always-On Insights Solutions to Local Brand and Experience Leaders
BERLIN, DE / ACCESS Newswire / December 16, 2025 / Market Logic Software, the market-leading SaaS provider of insight management solutions, has announced a partnership with Matter, a New
Why Rocket Lab Stock Keeps Going Up
Rocket Lab (NASDAQ: RKLB) stock rocketed to a 10th straight day of gains Friday, surging 5.7% through 11:15 a.m. ET after announcing the New Zealand-based space company announced yet another big


